Journal
CURRENT ALLERGY AND ASTHMA REPORTS
Volume 12, Issue 5, Pages 396-401Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11882-012-0281-4
Keywords
Idiopathic CD4 lymphopenia; Immunodeficiency; Mutation; UNC119; Gene; T Cell function; LCK; TCR; T cell; T Cell receptor
Categories
Funding
- NIH [R01 AI0059719, PPG HL36577]
- Sheldon C. Siegel - Asthma and Allergy Foundation of America (AAFA)
- Colorado Clinical and Translational Sciences Institute (CCTSI) Junior Faculty Pilot Award (NIH/NCRR Colorado) [CTSI UL1 RR025780]
- CCTSI KL2 Research Scholar Award (NIH/NCRR Colorado) [CTSI KL2 RR025779]
Ask authors/readers for more resources
The activation of a T cell through T cell receptor (TCR) is fundamental to adaptive immune responses. The lymphocyte specific kinase (LCK) plays a central role in the initiation of signaling from the TCR. TCR activates LCK through the adaptor protein uncoordinated 119 (UNC119). A mutation of human UNC119 impairs LCK activation and is associated with inadequate signaling, diminished T cell responses to TCR stimulation, CD4 lymphopenia, and infections of viral, bacterial, and fungal origin. The above clinical and immunological findings meet the criteria of the idiopathic CD4 lymphopenia (ICL). The discovery of the UNC119 defect provides a molecular mechanism for a subset of patients with this previously unexplained disease. Here we review our recent findings on the UNC119 mutation in ICL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available